Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges

Area of Science:

• Otolaryngology
• Genetics
• Regenerative Medicine

Background:

• Hearing impairment is a prevalent sensory deficit across all age groups, with over 50% of congenital deafness being hereditary.
• Major causes include genetic predisposition, aging, acoustic trauma, ototoxic drugs, and noise exposure.
• Current management relies on hearing aids and cochlear implants, which do not restore native inner ear function.

Purpose of the Study:

• To review advancements in understanding inherited deafness and its underlying mechanisms.
• To highlight the development of novel therapeutic strategies for sensorineural hearing loss.
• To discuss the successful restoration of auditory and vestibular functions in preclinical models.

Main Methods:

• Review of studies on inherited deafness and animal models.
• Analysis of molecular, cellular, and physiological mechanisms of hearing loss.
• Evaluation of gene transfer and gene editing approaches for inner ear repair.

Main Results:

• Deciphering molecular mechanisms of inherited deafness through genetic studies.
• Development of gene-based therapies showing promise in animal models.
• Successful restoration of auditory and vestibular functions in specific inner ear conditions.

Conclusions:

• Gene therapy and gene editing offer potential curative treatments for sensorineural deafness.
• Preclinical successes pave the way for future clinical applications in restoring hearing.
• Further research is crucial for translating these findings into effective human therapies.